GCO.N

Genesco Inc Reports Third Quarter Fiscal 2025 Financial Results

authorIntellectia.AI

2024-12-062mins

Genesco Inc. Reports Third Quarter Fiscal 2025 Financial Results

Genesco Inc. (NYSE: GCO) today announced its financial outcomes for the third quarter, concluding on November 2, 2024.

Key Financial Metrics

Metric Q3 2025 Q3 2024 YoY Change
Net Sales $596M $579M +3%
Non-GAAP EPS $0.61 $0.57 +7%

Genesco's financial performance in the third quarter exceeded expectations, highlighted by a 3% increase in net sales to $596 million, fueled by a 6% rise in comparable sales. Notably, the adjusted earnings per share rose to $0.61, reflecting strong operational execution.

Segment Revenue Performance

Segment Q3 2025 Change From Prior Year
Journeys +4% Meets expectations
Schuh +3% Below, down 2% constant currency
Genesco Brands +10% Solid growth
Johnston & Murphy -4% Below expectations

Revenue growth was robust across Genesco Brands with a 10% increase, while Journeys showed a strong 4% growth. Conversely, Schuh faced a decline in constant currency terms, and Johnston & Murphy underperformed.

Key Developments and Operational Highlights

  • Comparable e-commerce sales surged by 15%.
  • E-commerce sales represented 24% of total retail sales, up from 21% last year.
  • Despite 12 store closures at Journeys, cost-saving programs remain on track for a $45 to $50 million annualized run rate reduction by the end of Fiscal 2025.

Comments from Company Officers

Mimi E. Vaughn, the Board Chair, President, and CEO, emphasized the unexpected strong sales momentum, particularly in Journeys, which benefited from its strategic growth plan focusing on consumer experience enhancements. She highlighted cautiousness towards Schuh and Johnston & Murphy, given current consumer demand variability.

Share Repurchase Program

Genesco repurchased 17,922 shares, totaling $0.4 million, and maintains $42.3 million in its expanded authorization for future buybacks.

Forward Guidance

Genesco has raised its Fiscal 2025 outlook, projecting total sales to range from down 1% to flat. Adjusted EPS guidance is increased to the range of $0.80 to $1.00.

Overall, Genesco continues to execute its strategic initiatives successfully, driving growth in key areas while remaining prepared to address varying market conditions.

For more in-depth analysis and insights, stay tuned with our platform to stay ahead of the market.

Join Intellectia

Share

Want more financial insights delivered directly to your inbox?

Subscribe now and receive handpicked financial news, insights, and trending topics.